top of page

OUR RESEARCH ON NEWS, TV, BLOGS, OR VLOGS

About CSI Lab @KU Leuven

Welcome to the Laboratory of Cell Stress & Immunity (CSI)! Our lab is part of a world-leading university (KU Leuven) renowned for scientific excellence, breakthrough discoveries and innovation.

Why do some cancers respond to immunotherapy while others resist it, and how can we turn scientific discoveries into real patient benefit? Led by Prof. Abhishek D. Garg, the CSI lab bridges fundamental cancer immunology with clinical innovation through cutting-edge multi-omics, spatial biology, artificial intelligence (AI) and reverse translational research. Our journey starts with cancer patients: we analyze clinical samples and treatment outcomes to uncover immune mechanisms driving therapeutic response and resistance. We then translate these discoveries into predictive biomarkers for smarter patient selection, and next-generation immunotherapies to overcome resistance. Promising solutions undergo rigorous functional and preclinical validation, creating a foundation for future clinical development in partnership with leading oncologists, scientists and industry collaborators worldwide. Our ultimate mission is clear: fewer ineffective treatments, more personalized therapeutic decisions and better treatment options for patients with hard-to-treat cancers.

Do you want to support our patient-oriented research?

NEWS & SNIPPETS FROM OUR LAB

Our groundbreaking work on 'next generation' anticancer vaccines will be the basis for new clinical trials for patients, funded by EU Mission Cancer!

Congratulations to Dr. Isaure Vanmeerbeek for being awarded the Stichting Tegen Kanker (STK)'s postdoctoral research fellowship for her groundbreaking work!

Congratulations to Dr. Stefan Naulaerts (our former postdoc) for becoming a research professor & starting his own lab at KU Leuven, Belgium!

Our AI-powered lab-in-the-loop immunotherapy platform, RETROFIT, was recently launched. It will help translate our science into patient benefit!

Our lab's innovative research on clinical kidney cancer's immuno-oncology was selected by the Nature Medicine journal for a research highlight!

Our lab is joining forces with PharmAbs innovation platform to convert our novel targets into innovative antibody-based immunotherapies!

SPOTLIGHT RESEARCH, REVIEWS, EDITORIALS or BOOKS

  • KU Leuven
  • Department of Cellular & Molecular Medicine
  • X
  • LinkedIn
  • download
  • bluesky

© 2025 by Prof. Abhishek D. Garg. Ceated with Wix.com

bottom of page